Medical Patent News

RSS

Expiring patents drive drug spending's first time fall

Patient spending on prescription drugs fell in 2012 -- for the first time ever, a new study reports -- due in part to expiring patents on brand-name drugs.

10 May 2013

European Patent Office issues notice of intent to grant patent for Nuvo Research's PENNSAID 2%

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain today announced that the European Patent Office has issued a notice of Intention to Grant a European Patent that provides protection for the Company's PENNSAID 2% product.

9 May 2013

IDIBELL signs patent licensing agreement with Minoryx

The Bellvittge Biomedical Research Institute has signed a licensing agreement with the Spanish biotechnology company Minoryx of a patent for the treatment of X-linked adrenoleukodystrophy, a rare serious neurodegenerative disease which has no effective treatment.

8 May 2013

Entremed reports patent issuance for its lead drug candidate ENMD-2076

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of a variety of cancers, today announced the issuance by the Chinese State Intellectual Property Office of Patent Certificate No. ZL 200680044656.7.

7 May 2013

EntreMed announces issuance of patent for clinical-stage compound, 2-methoxyestradiol

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of a variety of cancers, announced the issuance of a U.S. patent covering methods of treatment and formulations for its clinical-stage compound, 2-methoxyestradiol.

3 May 2013

Absorption Pharmaceuticals to obtain patent for Promescent medication

Absorption Pharmaceuticals announced today that the U.S. Patent and Trademark Office has indicated that it will grant a patent related to the use of its topical medication, Promescent, for premature ejaculation.

29 Apr 2013

HHS global health official discusses tobacco-, drug patent-related trade negotiations

Inside U.S. Trade features an interview with HHS Assistant Secretary forAffairs Nils Daulaire, who discusses how "the department is playing a larger role than ever before in the development of U.S. trade policy, including on sensitive issues in the Trans-Pacific Partnership (TPP) negotiations like a draft proposal for a tobacco-specific 'safe harbor' and the U.S. stance on issues related to intellectual property protections for pharmaceuticals," according to the publication.

25 Apr 2013

South Africa aims to close drug patent loophole that allows for 'ever-greening'

"South Africa plans to overhaul its intellectual property laws to improve access to cheaper medicines by making it harder for pharmaceutical firms to register and roll-over patents for drugs, a senior official said on Monday," Reuters reports.

24 Apr 2013

Catheter Connections receives another patent for IV disinfection technology

Catheter Connections, a start-up company co-founded by nurses seeking to reduce deadly hospital-acquired bloodstream infections, announced today the issuance of U.S. Patent Number 8,419,713, titled "Carrier Assembly With Caps for Medical Connectors."

18 Apr 2013

High court seems skeptical that biotech firm can patent human genes

Supreme Court justices seemed to express skepticism Monday that a biotech company can patent human genes isolated from the body that signal a greater likelihood of ovarian or breast cancer.

17 Apr 2013

First Edition: April 16, 2013

Today's headlines include coverage of the Supreme Court oral arguments regarding whether patents should be granted for human genes.

16 Apr 2013

Supreme Court to decide crucial case on patenting human genes

The high court will hear a challenge to Myriad Genetics' patent of breast and ovarian cancer genes in a case that will affect the future of biomedical research, the fight against diseases like breast and ovarian cancer and a multi-billion dollar biotechnology business.

16 Apr 2013

FDA finds violations at 28 drug compounding pharmacies

The FDA has found safety violations at 28 of 29 compounding pharmacies that are supposed to be producing sterile drugs.

16 Apr 2013

Drug makers must change R&D practices or patent disputes will continue

"[T]he impact of [a decision by the Supreme Court in India to disallow a new patent for an updated version of Novartis' cancer drug Glivec] will likely be broader than just that issue, escalating a long-simmering fight over patented cancer medications in emerging markets," Thomas Bollyky, senior fellow for global health, economics, and development at the Council on Foreign Relations and an adjunct professor of law at Georgetown University, writes in an Atlantic opinion piece.

15 Apr 2013

mPhase Technologies files patent application for novel drug delivery system

mPhase Technologies, Inc. said today that it is pursuing licensing opportunities for its Smart Drug Delivery System.

10 Apr 2013

Patent covering methods of treating ALS receives notice of allowance

Neuralstem, Inc. announced today that it received a notice of allowance for patent application 12/404,841. This patent covers methods for treating amyotrophic lateral sclerosis (ALS or Lou Gehrig 's disease) with expanded spinal cord stem cells, including NSI-566.

6 Apr 2013

India's Supreme Court ruling on drug patent will promote affordable medicines, 'preserve' innovation incentives

Noting that India's Supreme Court on Monday ruled that drug maker Novartis "should not be given a patent for a cancer drug because it was too similar to Novartis's earlier version," a New York Times editorial writes, "The decision, which is the culmination of a high-profile, seven-year legal battle, should help protect the availability of cheap generic drugs for poor patients."

6 Apr 2013

Medical Patent News

Expiring patents drive drug spending's first time fall

European Patent Office issues notice of intent to grant patent for Nuvo Research's PENNSAID 2%

IDIBELL signs patent licensing agreement with Minoryx

Entremed reports patent issuance for its lead drug candidate ENMD-2076

EntreMed announces issuance of patent for clinical-stage compound, 2-methoxyestradiol

Absorption Pharmaceuticals to obtain patent for Promescent medication

HHS global health official discusses tobacco-, drug patent-related trade negotiations

South Africa aims to close drug patent loophole that allows for 'ever-greening'

Catheter Connections receives another patent for IV disinfection technology

High court seems skeptical that biotech firm can patent human genes

First Edition: April 16, 2013

Supreme Court to decide crucial case on patenting human genes

FDA finds violations at 28 drug compounding pharmacies

Drug makers must change R&D practices or patent disputes will continue

mPhase Technologies files patent application for novel drug delivery system

Patent covering methods of treating ALS receives notice of allowance

India's Supreme Court ruling on drug patent will promote affordable medicines, 'preserve' innovation incentives

USPTO issues Notice of Allowance on Antares Pharma's patent application for VIBEX QS device

Reuters examines implications of India's Novartis patent ruling for big pharma

Oramed Pharmaceuticals receives Japanese patent for innovative oral delivery technology

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News